Norwich Ventures
Venture capitalWaltham · Seed–Series A · 1 people tracked
Investment thesis
Norwich Ventures seeks passionate founders with capital-efficient, best-in-class medical technologies that address large unmet clinical needs across diverse medical specialties. The firm values clear barriers to entry and rapid paths to proof of concept, backing entrepreneurs across therapeutic areas including electrophysiology, genomics, and women's health.
Source: firm website, verified Jul 21, 2026.
Team · 1 people
from the firm's websiteWhat they invest in
from 4 of 10 portfolio companiesMedical Devices ×4Biotech ×2Healthtech ×2Deep Tech ×1Digital Health ×1Hardware ×1
HQs:United States×1
Investments · 10 tracked
founders shown can be your intro pathIonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.
BiotechDeep TechMedical Devices
Podimetrics develops a remote monitoring solution combining the SmartMat device and personalized support to identify high-risk individuals with complex diabetes and enable early intervention to prevent complications. The platform serves payors, healthcare providers, and employers aiming to reduce amputations, hospitalizations, and overall healthcare costs.
Digital HealthHealthtechMedical Devices
Lexington Medical manufactures surgical staplers and stapling devices, including the AEON Endostapler for procedures like lung volume reduction surgery. The company serves healthcare institutions and surgical teams.
HardwareMedical DevicesBedford, US
Jameson Kief(Director of Engineering)
Terrestrial develops the Tacterra microarray patch platform, a dissolvable skin-patch technology for delivering therapies including GLP-1 without injection. The platform targets patients seeking more convenient, pain-free administration of next-generation therapeutics.
BiotechHealthtechMedical Devices
Rachel Sha(CEO)
Frequently asked questions
- What stage does Norwich Ventures invest at?
- Norwich Ventures invests at the Seed, Series A stages.
- What sectors does Norwich Ventures focus on?
- Norwich Ventures focuses on Medical Devices.
- Where is Norwich Ventures located?
- Norwich Ventures is headquartered in Waltham, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.